Schedule 13D ownership disclosure

HEXO CORP

Security class unavailable · CUSIP: 428304307

Event date: 2023-03-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-073878
Form type
SC 13D
Filer
Carisma Therapeutics Inc.
CIK
CIK 1485003
Filed
Mar 17, 2023
Reporting period
Mar 17, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub